Rajendiran Smrithi, Boyer Scott W, Forsberg E Camilla
Institute for the Biology of Stem Cells, Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Institute for the Biology of Stem Cells, Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Stem Cell Res. 2020 Dec 29;50:102145. doi: 10.1016/j.scr.2020.102145.
Hematopoietic stem and progenitor cell (HSPC) transplantation is the paradigm for stem cell therapies. The protocol described here enables quantitative assessment of the body-wide HSPC reconstitution of different mature hematopoietic cells in mice based on their presence in circulating blood. The method determines donor-derived mature cell populations per mouse, over time, by quantitatively obtaining their absolute numbers in the peripheral blood and utilizing previously assessed tissue-distribution factors. A Markov-based birth/death computational model accounts for the drastic differences in mature cell half-lives. By quantifying the number of cells produced and eliminating host variability, the protocol can be used to directly compare the lineage output of different types of HSPCs on a per cell basis, thereby clarifying the lineage potential and expansion capacity of different cell populations. These protocols were developed for hematopoiesis, but can readily be extended to other contexts by simply replacing the cell types and distributions.
造血干细胞和祖细胞(HSPC)移植是干细胞疗法的典范。本文所述方案能够基于循环血液中不同成熟造血细胞的存在情况,对小鼠体内全身HSPC向不同成熟造血细胞的重建进行定量评估。该方法通过定量获取外周血中它们的绝对数量并利用先前评估的组织分布因子,随时间确定每只小鼠供体来源的成熟细胞群体。基于马尔可夫的出生/死亡计算模型考虑了成熟细胞半衰期的巨大差异。通过量化产生的细胞数量并消除宿主变异性,该方案可用于在单个细胞基础上直接比较不同类型HSPC的谱系输出,从而阐明不同细胞群体的谱系潜能和扩增能力。这些方案是针对造血作用开发的,但通过简单替换细胞类型和分布,可轻松扩展到其他情况。